Prof. Peng Zhang 张鹏
Chief Physician, Professor
Department of Bone and Soft Tissue Tumors, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of spinal tumors (primary and metastatic). Standardized, individualized comprehensive care for bone tumors (osteosarcoma, Ewing sarcoma, giant cell tumor) and soft tissue sarcomas.
Dr. Zhang is a Chief Physician, Professor, and Master’s supervisor at Henan Cancer Hospital. Clinical focus includes limb-salvage surgery and neoadjuvant chemotherapy for primary malignant bone and soft tissue sarcomas, individualized care for spinal metastases, limb-salvage surgery for extremity metastases, and reconstruction after tumor resection.
Name order: in Chinese the family name comes first (Zhang Peng). Papers usually list the name as Peng Zhang or Zhang P.
Selected publications
121 papers on PubMed matched by name and affiliation; 27 as first or senior author since 2016. Most recent first- or senior-author papers:
- Global Spine J, 2026 (senior author): Difference and Correlation Between Standing and Supine Cervical Sagittal Alignment: DTS vs MRI. PubMed 41570839
- Synth Syst Biotechnol, 2026 (senior author): Engineered dual-fluorescence functional nucleic acid-based CRISPR/Cas12a biosensor for label-free ratiometric detection of site-specific DNA methylation. PubMed 41321596
- Int J Surg, 2026 (senior author): Cancer-associated fibroblast exosomal miR-214-3p regulated by hnRNPA2B1 promotes cisplatin resistance by inhibiting ferroptosis. PubMed 41405275
- Cell Signal, 2026 (senior author): Corrigendum to' Rab27a(+) CAF-derived exosomal miR-9-5p promotes osteosarcoma progression via CREBRF/MAPK signaling pathway', [Cellular Signaling Oct:134(2025):111964-111975]. PubMed 41077500
- Synth Syst Biotechnol, 2025 (senior author): A multifunctional switch for label-free CRISPR/Cas12a sensor with self-driven amplification. PubMed 40735058
- Spine J, 2025 (senior author): Predicting survival outcomes in renal cell carcinoma spinal metastases: a multicenter evaluation of existing prognostic systems. PubMed 40348282
- Sci Rep, 2025 (first author): Exosomal miR-20a-5p derived from cisplatin-resistant osteosarcoma cells promotes chemoresistance via Inhibition of ferroptosis through targeting RUNX3. PubMed 41310057
- Biosens Bioelectron, 2025 (senior author): CRISPR/Cas12a-mediated DNAzyme/split-aptamer cascade for label-free detection of site-specific DNA methylation. PubMed 40555107
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion